ProShares UltraShort Nasdaq Biotechnology (BIS) Institutional Ownership → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free BIS Stock Alerts $20.58 +0.49 (+2.44%) (As of 04/25/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$450.54KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$97.65K Get BIS Insider Trade Alerts Want to know when executives and insiders are buying or selling ProShares UltraShort Nasdaq Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIS Institutional Buying and Selling by Quarter Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 ProShares UltraShort Nasdaq Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/13/2024 IMC Chicago LLC25,210$443K0.0%+68.1%11.459% 2/13/2024Tower Research Capital LLC TRC4,721$85K0.0%-53.4%1.004% 2/9/2024 IMC Chicago LLC15,001$271K0.0%N/A3.192% 11/10/2022Tower Research Capital LLC TRC8,123$205K0.0%-9.2%2.708% 11/8/2022 IMC Chicago LLC23,335$590K0.0%+11.1%7.778% 8/5/2022 IMC Chicago LLC21,003$566K0.0%+12.5%5.251% Get the Latest News and Ratings for BIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 8/5/2022OLD Mission Capital LLC15,311$413K0.0%-52.5%3.828% 4/19/2022 IMC Chicago LLC18,668$450K0.0%N/A5.395% 2/10/2022OLD Mission Capital LLC13,257$266K0.0%N/A3.348% 11/5/2021 IMC Chicago LLC27,459$495K0.0%+93.3%6.934% 8/13/2021OLD Mission Capital LLC30,214$556K0.0%-33.8%6.774% 8/11/2021Susquehanna International Group LLP34,616$637K0.0%-26.5%7.761% 8/6/2021 IMC Chicago LLC14,203$261K0.0%+5.4%3.185% 5/18/2021Citadel Advisors LLC11,342$256K0.0%N/A2.543% 2/17/2021 IMC Chicago LLC11,604$273K0.0%N/A2.125% 2/13/2021Wealthsource Partners LLC18,050$425K0.0%-5.2%3.639% 1/13/2021Sowell Financial Services LLC2,285$54K0.0%N/A0.512% 11/16/2020Wealthsource Partners LLC19,050$590K0.1%-72.4%4.271% 8/17/2020Wealthsource Partners LLC69,000$555K0.1%+360.0%4.495% 7/27/2020Lindbrook Capital LLC9,000$72K0.0%N/A0.568% 7/13/2020Simplex Trading LLC8,743$70K0.0%+20.2%0.589% 5/15/2020Jane Street Group LLC46,459$655K0.0%N/A3.480% 5/15/2020Tower Research Capital LLC TRC13,178$186K0.0%+6,328.3%0.987% 5/15/2020Morgan Stanley7,678$108K0.0%+984.5%0.575% 5/12/2020Wealthsource Partners LLC15,000$212K0.0%-81.9%1.167% 4/29/2020Simplex Trading LLC7,276$102K0.0%+1,235.0%0.566% (Data available from 1/1/2016 forward) BIS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIS shares? During the previous two years, the following institutional investors and hedge funds held shares of ProShares UltraShort Nasdaq Biotechnology shares: IMC Chicago LLC ($443K), and OLD Mission Capital LLC ($413K), Tower Research Capital LLC TRC ($85K).Learn more on BIS's institutional investors. Which institutional investors have been buying ProShares UltraShort Nasdaq Biotechnology stock? The following institutional investors have purchased ProShares UltraShort Nasdaq Biotechnology stock in the last 24 months: IMC Chicago LLC ($29.88K). How much institutional buying is happening at ProShares UltraShort Nasdaq Biotechnology? Institutional investors have bought a total of 29,877 shares in the last 24 months. This purchase volume represents approximately $694.26K in transactions. Which ProShares UltraShort Nasdaq Biotechnology major shareholders have been selling company stock? The following institutional investors have sold ProShares UltraShort Nasdaq Biotechnology stock in the last 24 months: OLD Mission Capital LLC ($16.90K), and Tower Research Capital LLC TRC ($6.23K). How much institutional selling is happening at ProShares UltraShort Nasdaq Biotechnology? Institutional investors have sold a total of 23,122 shares in the last 24 months. This volume of shares sold represents approximately $1.05M in transactions. Related Companies: First Trust Nasdaq Pharmaceuticals ETF Institutional Ownership Invesco Nasdaq Biotechnology ETF Institutional Ownership Principal Healthcare Innovators ETF Institutional Ownership ProShares Ultra Nasdaq Biotechnology Institutional Ownership Invesco Dorsey Wright Healthcare Momentum ETF Institutional Ownership Invesco S&P SmallCap Health Care ETF Institutional Ownership VanEck Biotech ETF Institutional Ownership VanEck Pharmaceutical ETF Institutional Ownership iShares Biotechnology ETF Institutional Ownership This page (NASDAQ:BIS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
